JP2006525944A5 - - Google Patents

Download PDF

Info

Publication number
JP2006525944A5
JP2006525944A5 JP2004570427A JP2004570427A JP2006525944A5 JP 2006525944 A5 JP2006525944 A5 JP 2006525944A5 JP 2004570427 A JP2004570427 A JP 2004570427A JP 2004570427 A JP2004570427 A JP 2004570427A JP 2006525944 A5 JP2006525944 A5 JP 2006525944A5
Authority
JP
Japan
Prior art keywords
alkyl
pharmaceutically acceptable
acceptable salt
compound
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004570427A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006525944A (ja
JP4601429B2 (ja
Filing date
Publication date
Priority claimed from US10/714,066 external-priority patent/US7202259B2/en
Application filed filed Critical
Publication of JP2006525944A publication Critical patent/JP2006525944A/ja
Publication of JP2006525944A5 publication Critical patent/JP2006525944A5/ja
Application granted granted Critical
Publication of JP4601429B2 publication Critical patent/JP4601429B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004570427A 2002-11-18 2003-11-17 疼痛治療用4−テトラゾリル−4フェニルピペリジン誘導体 Expired - Fee Related JP4601429B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US42738102P 2002-11-18 2002-11-18
US46027803P 2003-04-03 2003-04-03
US48848803P 2003-07-17 2003-07-17
US10/714,066 US7202259B2 (en) 2002-11-18 2003-11-13 Therapeutic agents useful for treating pain
PCT/US2003/036742 WO2004046132A1 (en) 2002-11-18 2003-11-17 4-tetrazolyl-4phenylpiperidine derivatives for treating pain

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010056560A Division JP2010163452A (ja) 2002-11-18 2010-03-12 疼痛治療用4−テトラゾリル−4フェニルピペリジン誘導体

Publications (3)

Publication Number Publication Date
JP2006525944A JP2006525944A (ja) 2006-11-16
JP2006525944A5 true JP2006525944A5 (enExample) 2007-01-11
JP4601429B2 JP4601429B2 (ja) 2010-12-22

Family

ID=32777221

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004570427A Expired - Fee Related JP4601429B2 (ja) 2002-11-18 2003-11-17 疼痛治療用4−テトラゾリル−4フェニルピペリジン誘導体
JP2010056560A Pending JP2010163452A (ja) 2002-11-18 2010-03-12 疼痛治療用4−テトラゾリル−4フェニルピペリジン誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010056560A Pending JP2010163452A (ja) 2002-11-18 2010-03-12 疼痛治療用4−テトラゾリル−4フェニルピペリジン誘導体

Country Status (36)

Country Link
US (3) US7202259B2 (enExample)
EP (2) EP1803718B1 (enExample)
JP (2) JP4601429B2 (enExample)
KR (1) KR20050115221A (enExample)
CN (2) CN101648941A (enExample)
AP (1) AP2210A (enExample)
AR (1) AR047008A1 (enExample)
AT (2) ATE402167T1 (enExample)
AU (2) AU2003294313B2 (enExample)
BR (1) BR0316305A (enExample)
CA (1) CA2506242C (enExample)
CO (1) CO5690588A2 (enExample)
CR (2) CR7877A (enExample)
CY (2) CY1107682T1 (enExample)
DE (2) DE60322451D1 (enExample)
DK (2) DK1562932T3 (enExample)
EA (1) EA008621B1 (enExample)
EC (1) ECSP055840A (enExample)
ES (2) ES2285235T3 (enExample)
GE (1) GEP20084539B (enExample)
IL (1) IL209352A0 (enExample)
IS (2) IS2720B (enExample)
MA (1) MA27565A1 (enExample)
ME (1) MEP48108A (enExample)
MX (1) MXPA05004669A (enExample)
MY (1) MY135647A (enExample)
NI (1) NI200500087A (enExample)
NO (1) NO20052894L (enExample)
NZ (2) NZ572685A (enExample)
OA (1) OA13010A (enExample)
PT (2) PT1562932E (enExample)
RS (1) RS51047B (enExample)
SG (1) SG165998A1 (enExample)
SI (2) SI1803718T1 (enExample)
TW (2) TWI343917B (enExample)
WO (1) WO2004046132A1 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7202259B2 (en) * 2002-11-18 2007-04-10 Euro-Celtique S.A. Therapeutic agents useful for treating pain
ME00276B (me) 2003-04-30 2011-05-10 Purdue Pharma Lp Transdermalni dozni oblik otporan na promjene koje sadrže komponentu aktivnog sredstva i komponentu suprotnog sredstva na mjestu koji je ispod sloja aktivnog sredstva
US8790689B2 (en) * 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
BRPI0506548A (pt) * 2004-01-30 2007-05-02 Euro Celtique Sa métodos para produzir compostos de 4-tetrazolil-4-fenilpiperidina
SE0401656D0 (sv) * 2004-06-24 2004-06-24 Astrazeneca Ab Chemical compounds
CA2628750C (en) * 2005-11-21 2013-02-12 Purdue Pharma L.P. 4-oxadiazolyl-piperidine compounds and use thereof
US20080051380A1 (en) 2006-08-25 2008-02-28 Auerbach Alan H Methods and compositions for treating cancer
WO2011056561A1 (en) 2009-10-27 2011-05-12 Beth Israel Deaconess Medical Center Methods and compositions for the generation and use of conformation-specific antibodies
ES2566828T3 (es) 2010-09-21 2016-04-15 Purdue Pharma L.P. Análogos de buprenorfina como agonistas y/o antagonistas del receptor opioide
CN102648915B (zh) * 2011-02-28 2015-04-15 鲁南制药集团股份有限公司 一种治疗或预防神经病理性疼痛的药物组合物
US10487114B2 (en) 2011-04-27 2019-11-26 Beth Israel Deaconess Medical Center, Inc. Methods for administering peptides for the generation of effective c/s conformation-specific antibodies to a human subject in need thereof
EP2917182B1 (en) 2012-11-09 2018-01-03 Purdue Pharma LP Benzomorphan analogs and the use thereof
US9175000B2 (en) 2012-12-07 2015-11-03 Purdue Pharma L.P. Buprenorphine analogs
US8980906B2 (en) 2012-12-14 2015-03-17 Purdue Pharma L.P. Pyridonemorphinan analogs and biological activity on opioid receptors
US8987287B2 (en) 2012-12-14 2015-03-24 Purdue Pharma L.P. Spirocyclic morphinans and their use
EP2951160B1 (en) 2013-01-31 2019-04-24 Purdue Pharma LP Benzomorphan analogs and the use thereof
US8969358B2 (en) 2013-03-15 2015-03-03 Purdue Pharma L.P. Buprenorphine analogs
WO2015097548A1 (en) 2013-12-26 2015-07-02 Purdue Pharma L.P. 7-beta-alkyl analogs of orvinols
WO2015097547A1 (en) 2013-12-26 2015-07-02 Purdue Pharma L.P. 10-substituted morphinan hydantoins
WO2015097545A1 (en) 2013-12-26 2015-07-02 Purdue Pharma L.P. Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans
WO2015100174A1 (en) 2013-12-26 2015-07-02 Purdue Pharma L.P. Ring-contracted morphinans and the use thereof
US9340542B2 (en) 2013-12-26 2016-05-17 Purdue Pharma L.P. Propellane-based compounds and the use thereof
WO2015099863A1 (en) 2013-12-27 2015-07-02 Purdue Pharma L.P. 6-substituted and 7-substituted morphinan analogs and the use thereof
CA2950567A1 (en) 2014-05-27 2015-12-03 Purdue Pharma L.P. Spirocyclic morphinans and use thereof
JP6360915B2 (ja) 2014-06-13 2018-07-18 パーデュー、ファーマ、リミテッド、パートナーシップ アザモルフィナン誘導体及びその使用
MA41125A (fr) 2014-12-05 2017-10-10 Purdue Pharma Lp Dérivés de 6.7-cyclomorphinane et leur utilisation
CA3018750A1 (en) 2016-03-22 2017-09-28 Regents Of The University Of Minnesota Combination for treating pain
IL322013A (en) 2016-07-29 2025-09-01 Janssen Pharmaceutica Nv Niraparib or its salts for use in the treatment of prostate cancer
WO2018125716A1 (en) 2017-01-02 2018-07-05 Purdue Pharma L.P. Morphinan derivatives and use thereof
JP2024518804A (ja) * 2021-05-21 2024-05-02 パーデュー、ファーマ、リミテッド、パートナーシップ 間質性膀胱炎/膀胱痛症候群を処置する方法
CN119421705A (zh) * 2022-06-24 2025-02-11 普渡制药公司 治疗或预防膀胱过度活动综合征的方法

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536809A (en) * 1969-02-17 1970-10-27 Alza Corp Medication method
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
BE775611A (fr) 1970-11-24 1972-03-16 Synthelabo Derives de la (diphenyl-3,3 propyl-1)-1 piperidine, leur preparation etles medicaments qui en contiennent
US4076717A (en) * 1971-12-15 1978-02-28 G. D. Searle & Co. Derivatives of 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) * 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
DK162087D0 (da) * 1987-03-31 1987-03-31 Ferrosan As Piperidinforbindelser, deres fremstilling og anvendelse
US4831192A (en) * 1987-12-31 1989-05-16 Boc, Inc. Methods of preparing 4-heteropentacyclic-4-(N-phenyl)amido) piperidine derivatives and intermediate compounds
US5073543A (en) * 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
IT1229203B (it) * 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
US5120548A (en) * 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
US5733566A (en) * 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5698155A (en) * 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5449989A (en) 1992-07-31 1995-09-12 Correa; Paulo N. Energy conversion system
US5606037A (en) 1992-11-09 1997-02-25 Biochem Pharma Inc. Processes antineoplastic heteronaphthoquinones
US5736523A (en) 1992-11-09 1998-04-07 Biochem Pharma Inc. Antineoplastic heteronapthoquinones
US5591767A (en) * 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
IT1270594B (it) * 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
US6166085A (en) 1995-04-14 2000-12-26 The Regents Of The University Of California Method of producing analgesia
US5849737A (en) 1995-04-14 1998-12-15 The Regents Of The University Of California Compositions and methods for treating pain
AU6111796A (en) * 1995-06-12 1997-01-09 G.D. Searle & Co. Compositions comprising a cyclooxygenase-2 inhibitor and a 5 -lipoxygenase inhibitor
US6573282B1 (en) 1995-09-12 2003-06-03 Adolor Corporation Peripherally active anti-hyperalgesic opiates
US5849761A (en) 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
AU1208397A (en) 1995-12-28 1997-07-28 Takeda Chemical Industries Ltd. Diphenylmethane derivatives as mip-1alpha/rantes receptor antagonists
US6221888B1 (en) 1997-05-29 2001-04-24 Merck & Co., Inc. Sulfonamides as cell adhesion inhibitors
DE69704679T2 (de) * 1997-06-10 2001-09-13 Synthon Bv 4-phenylpiperidin-derivate
WO1999045011A1 (en) 1998-03-06 1999-09-10 Janssen Pharmaceutica N.V. Glycine transport inhibitors
US6423519B1 (en) * 1998-07-15 2002-07-23 Gpc Biotech Inc. Compositions and methods for inhibiting fungal growth
PE20001420A1 (es) 1998-12-23 2000-12-18 Pfizer Moduladores de ccr5
US7217714B1 (en) 1998-12-23 2007-05-15 Agouron Pharmaceuticals, Inc. CCR5 modulators
CZ20013289A3 (cs) 1999-03-12 2002-01-16 Boehringer Ingelheim Pharmaceuticals, Inc. Sloučeniny výhodné jako protizánětové prostředky
WO2001021169A1 (en) 1999-09-20 2001-03-29 Takeda Chemical Industries, Ltd. Mch antagonists
CA2324330A1 (en) 1999-11-08 2001-05-08 Ssp Co., Ltd. 4-hydroxy-4-phenylpiperidine derivatives and pharmaceuticals containing the same
DE60022226D1 (de) 1999-12-06 2005-09-29 Euro Celtique Sa Benzimidazolverbindungen die nociceptinrezeptoraffinität haben
JP2003518130A (ja) 1999-12-22 2003-06-03 メルク フロスト カナダ アンド カンパニー 蛋白チロシンホスファターゼ1b(ptp−1b)阻害薬としてのホスホン酸誘導体
US6608052B2 (en) 2000-02-16 2003-08-19 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as anti-inflammatory agents
US6703525B2 (en) 2000-02-16 2004-03-09 Boehringer Ingelheim Pharmaceuticals, Inc. Sulfonamide intermediates and methods of producing same
AU4274401A (en) 2000-03-24 2001-10-03 Meiji Seika Kaisha Diphenylalkylamine derivatives useful as opioid delta receptor agonists
US6544981B2 (en) 2000-06-09 2003-04-08 Bristol-Myers Squibb Company Lactam inhibitors of factor Xa and method
CN1469862A (zh) 2000-10-12 2004-01-21 Ss制药株式会社 2,2-二苯基丁酰胺衍生物和含有它的药物
WO2002038185A2 (en) 2000-11-13 2002-05-16 Atrix Laboratories, Inc. Injectable sustained release delivery system with loperamide
US7202259B2 (en) * 2002-11-18 2007-04-10 Euro-Celtique S.A. Therapeutic agents useful for treating pain
BRPI0506548A (pt) * 2004-01-30 2007-05-02 Euro Celtique Sa métodos para produzir compostos de 4-tetrazolil-4-fenilpiperidina

Similar Documents

Publication Publication Date Title
JP2006525944A5 (enExample)
CA2506242A1 (en) 4-tetrazolyl-4phenylpiperidine derivatives for treating pain
RU2002107998A (ru) Сульфонилкарбоксамидные производные, способ их получения и их применение в качестве лекарственных средств
JP2001526269A5 (enExample)
RU99101081A (ru) Режим введения ингибиторов н+, к+-атфазы
RU2004104625A (ru) Аналоги простагландинов в качестве агонистов рецептора ep4
RU2002119019A (ru) Замещенные амидазолы-антагонисты рецептора Y5 нейропептида Y
RU2007111758A (ru) Аминопроизводные 7- амино-3-фенилдигидропиримидо [4,5-d] пиримидинонов, их получение и применение в качестве ингибиторов протеинкиназ
JP2005511699A5 (enExample)
JP2003500442A5 (enExample)
JP2007515447A5 (enExample)
RU2003137222A (ru) Замещенные амидом карбоновой кислоты производные фенилмочевины, способы их получения и их применение в качестве лекарственных средств
RU98120057A (ru) Производные d-пролина
JP2001526218A5 (enExample)
RU95113148A (ru) Производное 2-(2-амино-1,6-дигидро-6-оксопурин-9-ил)-метокси-1,3-пропандиола
JP2007507494A5 (enExample)
RU2004118423A (ru) Производные бензотиазола в качестве лигандов рецептора аденозина
JP2005517677A5 (enExample)
EP0397040A3 (en) N-heteroaryl-4-quinolinamines, a process for their preparation and their use as medicaments
JP2005519885A5 (enExample)
RU98106112A (ru) Производные пропаноламина, способы их получения, лекарственные средства, содержащие эти соединения и их применение
RU2007105968A (ru) Новые пиперидиновые производные для лечения депрессии
RU2002101622A (ru) Нафтохиноновые производные и их использование для лечения и борьбы с туберкулезом
RU2004101229A (ru) Дейтерированные n-и альфа-замещенные аминоалкилэфиры дифенилакоксиуксуной кислоты, а также лекарственные средства, содержащие эти соединения
RU2004133387A (ru) Фармацевтический препарат с немедленным высвобождением